MacroPore Biosurgery, Inc. Changes Name to Cytori Therapeutics, Inc.

12-Jul-2005 - MacroPore Biosurgery, Inc. announced it has changed its name to Cytori Therapeutics, Inc. The change was made to better reflect the company's focus and significant progress in the development of regenerative therapeutics. The Company will continue to trade its shares on the Frankfurt Stock ...

MacroPore Biosurgery Enters Agreement with Senko Medical for Thin Film Distribution Rights in Japan

Deal includes additional upside through minimum purchase requirements and royalties

20-Jul-2004 - MacroPore Biosurgery, Inc. announced that it has granted Senko Medical Trading Co. (Senko) exclusive sales and distribution rights to the thin film product line, including SurgiWrap(TM) and CardioWrap(TM), in Japan. In return for these rights, MacroPore Biosurgery will receive from Senko up to ...

MacroPore Biosurgery, Inc. sells bioresorbable thin film product line to MAST Biosurgery AG

17-May-2004 - MacroPore Biosurgery, Inc. announced today it has completed the sale of its bioresorbable thin film product line, which includes SurgiWrap(tm) and CardioWrap(tm), to MAST Biosurgery AG (MAST), which is held by a syndicate of investors led by Medicis Ventures Management GmbH (Medicis). MacroPore ...

MacroPore Awarded SBIR Grant from the NIH to Study the Use of Adipose-Derived Regenerative Cells for Treating Heart Attack

16-Jan-2004 - MacroPore Biosurgery, Inc. announced it has been awarded a Fast Track Phase I/II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to study the role of adipose-derived regenerative cells in treating myocardial infarction (heart attack). This research ...